Skip Navigation

Prospective Phase II Study of Cytochrome C Oxidase Activity as a Novel Biomarker In Subjects With Newly Diagnosed Primary Glioblastoma Multiforme

Brief Summary

Type:
Brain Tumors / Neurologic Cancers

Study Type:
Other

Phase:
II

ClinicalTrials.gov Identifier:
NCT02997423

Study #:
STUDY00140330

Start Date:
Jan 01, 0001

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT02997423

View Complete Trial Details & Eligibility at ClinicalTrials.gov